Skip to main content

Sanofi files appeal in case against Mylan over Epipen

Sanofi claimed Mylan, based in Canonsburg, had been anticompetitive in marketing EpiPen to the detriment of Auvi-Q and Sanofi.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.